How does blood glucose control with insulin save lives in intensive care

Patients requiring prolonged intensive care are at high risk for multiple organ failure and death. Insulin resistance and hyperglycemia accompany critical illness, and the severity of this "diabetes of stress" reflects the risk of death. Recently it was shown that preventing hyperglycemia with insulin substantially improves outcome of critical illness. This article examines some potential mechanisms underlying prevention of glucose toxicity as well as the effects of insulin independent of glucose control. Unraveling the molecular mechanisms will provide new insights into the pathogenesis of multiple organ failure and open avenues for novel therapeutic strategies.

[1]  A. Marette,et al.  Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  H. Harris,et al.  Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. , 1990, The Journal of clinical investigation.

[3]  M. Fink Clinical tests of gastrointestinal permeability that rely on the urinary recovery of enterally administered probes can yield invalid results in critically ill patients , 2002, Intensive Care Medicine.

[4]  S. Zakynthinos,et al.  Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock , 2001, Intensive Care Medicine.

[5]  A. Aljada,et al.  Insulin Inhibits Intranuclear Nuclear Factor κB and Stimulates IκB in Mononuclear Cells in Obese Subjects: Evidence for an Anti-inflammatory Effect? , 2001 .

[6]  M. Quon,et al.  Insulin-stimulated Activation of eNOS Is Independent of Ca2+ but Requires Phosphorylation by Akt at Ser1179 * , 2001, The Journal of Biological Chemistry.

[7]  S. Wong,et al.  Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat. , 1992, Biochimica et biophysica acta.

[8]  R. Vettor,et al.  Contact phase of blood coagulation in diabetes mellitus , 1982, European journal of clinical investigation.

[9]  B A Mizock,et al.  Alterations in fuel metabolism in critical illness: hyperglycaemia. , 2001, Best practice & research. Clinical endocrinology & metabolism.

[10]  P. Gaffney,et al.  Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage. , 1987, Thrombosis research.

[11]  R. Grimble Inflammatory status and insulin resistance , 2002, Current opinion in clinical nutrition and metabolic care.

[12]  A. K. Jonassen,et al.  Glucose-Insulin-Potassium Reduces Infarct Size When Administered During Reperfusion , 2000, Cardiovascular Drugs and Therapy.

[13]  G. Keusch,et al.  Infection and diabetes: the case for glucose control. , 1982, The American journal of medicine.

[14]  R. Krauss,et al.  The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. , 1993, The Journal of clinical endocrinology and metabolism.

[15]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[16]  A. Malhotra,et al.  Stress-induced hyperglycemia. , 2001, Critical care clinics.

[17]  M. Matthay,et al.  Hypoxia regulates gene expression of alveolar epithelial transport proteins. , 2000, Journal of applied physiology.

[18]  M. Carr Diabetes mellitus: a hypercoagulable state. , 2001, Journal of diabetes and its complications.

[19]  P. Watson,et al.  Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells. , 2000, Circulation research.

[20]  H. Lassen. A preliminary report on the 1952 epidemic of poliomyelitis in Copenhagen with special reference to the treatment of acute respiratory insufficiency. , 1953, Lancet.

[21]  R. Wolfe,et al.  Glucose metabolism in man: responses to intravenous glucose infusion. , 1979, Metabolism: clinical and experimental.

[22]  Y. Carpentier,et al.  Changes in the concentration and composition of plasma lipoproteins during the acute phase response , 2002, Current opinion in clinical nutrition and metabolic care.

[23]  D. Sodi-Pallares,et al.  Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. , 1962, The American journal of cardiology.

[24]  James Stephen Krinsley,et al.  Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. , 2004, Mayo Clinic proceedings.

[25]  Rüdiger Klein,et al.  Role of Brain Insulin Receptor in Control of Body Weight and Reproduction , 2000 .

[26]  M. Fink Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. , 2001, Critical care clinics.

[27]  J H Warner,et al.  Science in Medicine , 1985, Osiris.

[28]  M. White,et al.  Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. , 1999, The Journal of clinical investigation.

[29]  J. Callés-Escandon,et al.  Type 2 diabetes: one disease, multiple cardiovascular risk factors. , 1999, Coronary artery disease.

[30]  Claude Bernard,et al.  Leçons sur les phénomènes de la vie communs aux animaux et aux végétaux , 1878 .

[31]  M. Lotz,et al.  Cytokine Regulation of Facilitated Glucose Transport in Human Articular Chondrocytes1 , 2001, The Journal of Immunology.

[32]  L. Opie The glucose hypothesis: Relation to acute myocardial ischaemia , 1970 .

[33]  G. Grunkemeier,et al.  Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. , 1999, The Annals of thoracic surgery.

[34]  Miet Schetz,et al.  Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.

[35]  P. Kwiterovich Lipoprotein heterogeneity: diagnostic and therapeutic implications. , 2002, The American journal of cardiology.

[36]  G. Van den Berghe,et al.  Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. , 2003, The Journal of clinical endocrinology and metabolism.

[37]  D. Yellon,et al.  Myocardial Protection by Insulin at Reperfusion Requires Early Administration and Is Mediated via Akt and p70s6 Kinase Cell-Survival Signaling , 2001, Circulation research.

[38]  John Land,et al.  Association between mitochondrial dysfunction and severity and outcome of septic shock , 2002, The Lancet.

[39]  Nielson Cp,et al.  Inhibition of Polymorphonuclear Leukocyte Respiratory Burst by Elevated Glucose Concentrations in Vitro , 1989 .

[40]  G. Van den Berghe,et al.  Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. , 2002, The Journal of clinical endocrinology and metabolism.

[41]  T. Zimmers,et al.  Suppressor of Cytokine Signaling-3 (SOCS-3), a Potential Mediator of Interleukin-6-dependent Insulin Resistance in Hepatocytes* , 2003, The Journal of Biological Chemistry.

[42]  M. Quon,et al.  Inhibition of Phosphatidylinositol 3-Kinase Enhances Mitogenic Actions of Insulin in Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[43]  F Bruyninckx,et al.  Insulin therapy protects the central and peripheral nervous system of intensive care patients , 2005, Neurology.

[44]  G. Van den Berghe,et al.  Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. , 1999, The Journal of clinical endocrinology and metabolism.

[45]  B A Mizock,et al.  Alterations in carbohydrate metabolism during stress: a review of the literature. , 1995, The American journal of medicine.

[46]  G. Van den Berghe,et al.  A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. , 2002, Endocrinology.

[47]  M. Brownlee Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[48]  J. Ward,et al.  Electron microscopical studies of vessels in diabetic peripheral neuropathy. , 1980, Journal of clinical pathology.

[49]  O. McGuinness,et al.  Infection impairs insulin-dependent hepatic glucose uptake during total parenteral nutrition. , 2003, American journal of physiology. Endocrinology and metabolism.

[50]  M. Singer,et al.  Mitochondrial Dysfunction in Sepsis. , 1999, Current infectious disease reports.

[51]  H. Harris,et al.  Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. , 1993, The Journal of clinical investigation.

[52]  J. Medina,et al.  Endothelin‐1 stimulates the translocation and upregulation of both glucose transporter and hexokinase in astrocytes: relationship with gap junctional communication , 2004, Journal of neurochemistry.

[53]  D. Powell,et al.  Identification of an insulin-responsive element in the promoter of the human gene for insulin-like growth factor binding protein-1. , 1993, The Journal of biological chemistry.

[54]  R. Wolfe,et al.  Glucose metabolism in severely burned patients. , 1979, Metabolism: clinical and experimental.

[55]  A. Sumner,et al.  The physiology of lipoproteins , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[56]  G. Van den Berghe,et al.  A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. , 2000, The Journal of clinical endocrinology and metabolism.

[57]  J. Rask-Madsen,et al.  High glucose impairs superoxide production from isolated blood neutrophils , 2003, Intensive Care Medicine.

[58]  D. Accili,et al.  Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia. , 2000, Endocrinology.

[59]  M. Taskinen Pathogenesis of dyslipidemia in type 2 diabetes. , 2001, Experimental and clinical endocrinology & diabetes.

[60]  A. Marette Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings , 2002, Current opinion in clinical nutrition and metabolic care.

[61]  G. Schernthaner,et al.  Decreased Protein C Levels in Patients With Insulin-Dependent Type I Diabetes Mellitus , 1986, Diabetes.

[62]  G. Van den Berghe,et al.  Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. , 2003, Endocrinology.

[63]  W. Mccumbee,et al.  Regulation of glucose transport by angiotensin II and glucose in cultured vascular smooth muscle cells , 1998, Journal of cellular physiology.

[64]  A. Vincent,et al.  Oxidative Stress and Programmed Cell Death in Diabetic Neuropathy , 2002, Annals of the New York Academy of Sciences.

[65]  R. Wolfe,et al.  Effect of severe burn injury on substrate cycling by glucose and fatty acids. , 1987, The New England journal of medicine.

[66]  P. Pozzilli,et al.  Infections and Diabetes: Mechanisms and Prospects for Prevention , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[67]  B. Mcverry,et al.  Diabetes, a hypercoagulable state? Hemostatic variables in newly diagnosed type 2 diabetic patients. , 1983, Acta haematologica.

[68]  Timothy W. Evans,et al.  Glucose Control and Mortality in Critically Ill Patients , 2003 .

[69]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[70]  M. White,et al.  SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2* , 2002, The Journal of Biological Chemistry.

[71]  P. Barie,et al.  Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. , 1996, Critical care medicine.

[72]  G. Van den Berghe,et al.  Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. , 2004, The Journal of clinical endocrinology and metabolism.

[73]  E. Crouser,et al.  Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity , 2002, Critical care medicine.

[74]  C. Kahn,et al.  Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. , 2000, The Journal of clinical investigation.

[75]  D. Connolly,et al.  Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. , 1990, The Journal of biological chemistry.

[76]  P. Gaffney,et al.  Changes in fibrinolysis in the intensive care patient. , 1987, Thrombosis research.

[77]  T. Evans,et al.  Mechanisms of organ dysfunction in critical illness: report from a Round Table Conference held in Brussels , 2002, Intensive Care Medicine.

[78]  C. Carvalho,et al.  Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. , 1998, The New England journal of medicine.

[79]  U. Das Is insulin an antiinflammatory molecule? , 2001, Nutrition.

[80]  J Herlitz,et al.  Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. , 1995, Journal of the American College of Cardiology.

[81]  C. Wolf‐peeters,et al.  Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients , 2005, The Lancet.

[82]  M. Seppälä,et al.  Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. , 1988, The Journal of clinical endocrinology and metabolism.

[83]  F. Gao,et al.  Ischemia-Reperfusion : The Roles of PI 3-Kinase , Akt , and Endothelial Nitric Oxide Nitric Oxide Mediates the Antiapoptotic Effect of Insulin in Myocardial , 2002 .

[84]  Dieter Mesotten,et al.  Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. , 2004, The Journal of clinical endocrinology and metabolism.

[85]  Y. Mao,et al.  Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade , 2001, Critical care medicine.

[86]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[87]  D. Stuehr,et al.  Dynamics of protein nitration in cells and mitochondria. , 2004, American journal of physiology. Heart and circulatory physiology.

[88]  Bruce M. Spiegelman,et al.  Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction , 2003, Nature.

[89]  G. Mariani,et al.  Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. , 1992, Thrombosis research.

[90]  O. Ljungqvist,et al.  Insulin resistance: a marker of surgical stress. , 1999, Current opinion in clinical nutrition and metabolic care.

[91]  J. Wahren,et al.  Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. , 1994, The Journal of clinical endocrinology and metabolism.

[92]  K. Feingold,et al.  Infection and inflammation-induced proatherogenic changes of lipoproteins. , 2000, The Journal of infectious diseases.